Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur

Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-in...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	S. S. Rodionova [verfasserIn] A. I. Snetkov [verfasserIn] A. D. Akinshina [verfasserIn] I. V. Bulycheva [verfasserIn] A. N. Torgashin [verfasserIn] T. A. Grebennikova [verfasserIn] Zh. E. Belaya [verfasserIn] Е. M. Agafonova [verfasserIn] N. V. Toroptsova [verfasserIn] O. A. Nikitinskaya [verfasserIn]

Format:	E-Artikel
Sprache:	Russisch

Erschienen:	2019

Schlagwörter:	остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания

Übergeordnetes Werk:	In: Научно-практическая ревматология - IMA PRESS LLC, 2015, 57(2019), 6, Seite 708-712
Übergeordnetes Werk:	volume:57 ; year:2019 ; number:6 ; pages:708-712

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.14412/1995-4484-2019-708-712

Katalog-ID:	DOAJ083546073

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ083546073
003	DE-627
005	20230410120029.0
007	cr uuu---uuuuu
008	230311s2019 xx \|\|\|\|\|o 00\| \|\|rus c
024	7		\|a 10.14412/1995-4484-2019-708-712 \|2 doi
035			\|a (DE-627)DOAJ083546073
035			\|a (DE-599)DOAJ76e817c0e90e40e293169d3236594388
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a rus
050		0	\|a RC925-935
100	0		\|a S. S. Rodionova \|e verfasserin \|4 aut
245	1	0	\|a Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
264		1	\|c 2019
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored.
650		4	\|a остеомаляция
650		4	\|a фактор роста фибробластов 23
650		4	\|a опухоль
650		4	\|a гипофосфатемия
650		4	\|a метаболические заболевания
653		0	\|a Diseases of the musculoskeletal system
700	0		\|a A. I. Snetkov \|e verfasserin \|4 aut
700	0		\|a A. D. Akinshina \|e verfasserin \|4 aut
700	0		\|a I. V. Bulycheva \|e verfasserin \|4 aut
700	0		\|a A. N. Torgashin \|e verfasserin \|4 aut
700	0		\|a T. A. Grebennikova \|e verfasserin \|4 aut
700	0		\|a Zh. E. Belaya \|e verfasserin \|4 aut
700	0		\|a Е. M. Agafonova \|e verfasserin \|4 aut
700	0		\|a N. V. Toroptsova \|e verfasserin \|4 aut
700	0		\|a O. A. Nikitinskaya \|e verfasserin \|4 aut
773	0	8	\|i In \|t Научно-практическая ревматология \|d IMA PRESS LLC, 2015 \|g 57(2019), 6, Seite 708-712 \|w (DE-627)1736675966 \|x 19954492 \|7 nnns
773	1	8	\|g volume:57 \|g year:2019 \|g number:6 \|g pages:708-712
856	4	0	\|u https://doi.org/10.14412/1995-4484-2019-708-712 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/76e817c0e90e40e293169d3236594388 \|z kostenfrei
856	4	0	\|u https://rsp.mediar-press.net/rsp/article/view/2810 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1995-4484 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1995-4492 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 57 \|j 2019 \|e 6 \|h 708-712

Indexfelder

author_variant	s s r ssr a i s ais a d a ada i v b ivb a n t ant t a g tag z e b zeb е m a еma n v t nvt o a n oan
matchkey_str	article:19954492:2019----::yohshtmcsemlcanuebff3ertn
hierarchy_sort_str	2019
callnumber-subject-code	RC
publishDate	2019
allfields	10.14412/1995-4484-2019-708-712 doi (DE-627)DOAJ083546073 (DE-599)DOAJ76e817c0e90e40e293169d3236594388 DE-627 ger DE-627 rakwb rus RC925-935 S. S. Rodionova verfasserin aut Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored. остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания Diseases of the musculoskeletal system A. I. Snetkov verfasserin aut A. D. Akinshina verfasserin aut I. V. Bulycheva verfasserin aut A. N. Torgashin verfasserin aut T. A. Grebennikova verfasserin aut Zh. E. Belaya verfasserin aut Е. M. Agafonova verfasserin aut N. V. Toroptsova verfasserin aut O. A. Nikitinskaya verfasserin aut In Научно-практическая ревматология IMA PRESS LLC, 2015 57(2019), 6, Seite 708-712 (DE-627)1736675966 19954492 nnns volume:57 year:2019 number:6 pages:708-712 https://doi.org/10.14412/1995-4484-2019-708-712 kostenfrei https://doaj.org/article/76e817c0e90e40e293169d3236594388 kostenfrei https://rsp.mediar-press.net/rsp/article/view/2810 kostenfrei https://doaj.org/toc/1995-4484 Journal toc kostenfrei https://doaj.org/toc/1995-4492 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 57 2019 6 708-712
spelling	10.14412/1995-4484-2019-708-712 doi (DE-627)DOAJ083546073 (DE-599)DOAJ76e817c0e90e40e293169d3236594388 DE-627 ger DE-627 rakwb rus RC925-935 S. S. Rodionova verfasserin aut Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored. остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания Diseases of the musculoskeletal system A. I. Snetkov verfasserin aut A. D. Akinshina verfasserin aut I. V. Bulycheva verfasserin aut A. N. Torgashin verfasserin aut T. A. Grebennikova verfasserin aut Zh. E. Belaya verfasserin aut Е. M. Agafonova verfasserin aut N. V. Toroptsova verfasserin aut O. A. Nikitinskaya verfasserin aut In Научно-практическая ревматология IMA PRESS LLC, 2015 57(2019), 6, Seite 708-712 (DE-627)1736675966 19954492 nnns volume:57 year:2019 number:6 pages:708-712 https://doi.org/10.14412/1995-4484-2019-708-712 kostenfrei https://doaj.org/article/76e817c0e90e40e293169d3236594388 kostenfrei https://rsp.mediar-press.net/rsp/article/view/2810 kostenfrei https://doaj.org/toc/1995-4484 Journal toc kostenfrei https://doaj.org/toc/1995-4492 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 57 2019 6 708-712
allfields_unstemmed	10.14412/1995-4484-2019-708-712 doi (DE-627)DOAJ083546073 (DE-599)DOAJ76e817c0e90e40e293169d3236594388 DE-627 ger DE-627 rakwb rus RC925-935 S. S. Rodionova verfasserin aut Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored. остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания Diseases of the musculoskeletal system A. I. Snetkov verfasserin aut A. D. Akinshina verfasserin aut I. V. Bulycheva verfasserin aut A. N. Torgashin verfasserin aut T. A. Grebennikova verfasserin aut Zh. E. Belaya verfasserin aut Е. M. Agafonova verfasserin aut N. V. Toroptsova verfasserin aut O. A. Nikitinskaya verfasserin aut In Научно-практическая ревматология IMA PRESS LLC, 2015 57(2019), 6, Seite 708-712 (DE-627)1736675966 19954492 nnns volume:57 year:2019 number:6 pages:708-712 https://doi.org/10.14412/1995-4484-2019-708-712 kostenfrei https://doaj.org/article/76e817c0e90e40e293169d3236594388 kostenfrei https://rsp.mediar-press.net/rsp/article/view/2810 kostenfrei https://doaj.org/toc/1995-4484 Journal toc kostenfrei https://doaj.org/toc/1995-4492 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 57 2019 6 708-712
allfieldsGer	10.14412/1995-4484-2019-708-712 doi (DE-627)DOAJ083546073 (DE-599)DOAJ76e817c0e90e40e293169d3236594388 DE-627 ger DE-627 rakwb rus RC925-935 S. S. Rodionova verfasserin aut Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored. остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания Diseases of the musculoskeletal system A. I. Snetkov verfasserin aut A. D. Akinshina verfasserin aut I. V. Bulycheva verfasserin aut A. N. Torgashin verfasserin aut T. A. Grebennikova verfasserin aut Zh. E. Belaya verfasserin aut Е. M. Agafonova verfasserin aut N. V. Toroptsova verfasserin aut O. A. Nikitinskaya verfasserin aut In Научно-практическая ревматология IMA PRESS LLC, 2015 57(2019), 6, Seite 708-712 (DE-627)1736675966 19954492 nnns volume:57 year:2019 number:6 pages:708-712 https://doi.org/10.14412/1995-4484-2019-708-712 kostenfrei https://doaj.org/article/76e817c0e90e40e293169d3236594388 kostenfrei https://rsp.mediar-press.net/rsp/article/view/2810 kostenfrei https://doaj.org/toc/1995-4484 Journal toc kostenfrei https://doaj.org/toc/1995-4492 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 57 2019 6 708-712
allfieldsSound	10.14412/1995-4484-2019-708-712 doi (DE-627)DOAJ083546073 (DE-599)DOAJ76e817c0e90e40e293169d3236594388 DE-627 ger DE-627 rakwb rus RC925-935 S. S. Rodionova verfasserin aut Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored. остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания Diseases of the musculoskeletal system A. I. Snetkov verfasserin aut A. D. Akinshina verfasserin aut I. V. Bulycheva verfasserin aut A. N. Torgashin verfasserin aut T. A. Grebennikova verfasserin aut Zh. E. Belaya verfasserin aut Е. M. Agafonova verfasserin aut N. V. Toroptsova verfasserin aut O. A. Nikitinskaya verfasserin aut In Научно-практическая ревматология IMA PRESS LLC, 2015 57(2019), 6, Seite 708-712 (DE-627)1736675966 19954492 nnns volume:57 year:2019 number:6 pages:708-712 https://doi.org/10.14412/1995-4484-2019-708-712 kostenfrei https://doaj.org/article/76e817c0e90e40e293169d3236594388 kostenfrei https://rsp.mediar-press.net/rsp/article/view/2810 kostenfrei https://doaj.org/toc/1995-4484 Journal toc kostenfrei https://doaj.org/toc/1995-4492 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 57 2019 6 708-712
language	Russian
source	In Научно-практическая ревматология 57(2019), 6, Seite 708-712 volume:57 year:2019 number:6 pages:708-712
sourceStr	In Научно-практическая ревматология 57(2019), 6, Seite 708-712 volume:57 year:2019 number:6 pages:708-712
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания Diseases of the musculoskeletal system
isfreeaccess_bool	true
container_title	Научно-практическая ревматология
authorswithroles_txt_mv	S. S. Rodionova @@aut@@ A. I. Snetkov @@aut@@ A. D. Akinshina @@aut@@ I. V. Bulycheva @@aut@@ A. N. Torgashin @@aut@@ T. A. Grebennikova @@aut@@ Zh. E. Belaya @@aut@@ Е. M. Agafonova @@aut@@ N. V. Toroptsova @@aut@@ O. A. Nikitinskaya @@aut@@
publishDateDaySort_date	2019-01-01T00:00:00Z
hierarchy_top_id	1736675966
id	DOAJ083546073
language_de	russisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ083546073</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410120029.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2019 xx \|\|\|\|\|o 00\| \|\|rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14412/1995-4484-2019-708-712</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ083546073</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ76e817c0e90e40e293169d3236594388</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC925-935</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S. S. Rodionova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеомаляция</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фактор роста фибробластов 23</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">опухоль</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">гипофосфатемия</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">метаболические заболевания</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the musculoskeletal system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. I. Snetkov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. D. Akinshina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Bulycheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. N. Torgashin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. A. Grebennikova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zh. E. Belaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Е. M. Agafonova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. V. Toroptsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. A. Nikitinskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Научно-практическая ревматология</subfield><subfield code="d">IMA PRESS LLC, 2015</subfield><subfield code="g">57(2019), 6, Seite 708-712</subfield><subfield code="w">(DE-627)1736675966</subfield><subfield code="x">19954492</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:57</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:708-712</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14412/1995-4484-2019-708-712</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/76e817c0e90e40e293169d3236594388</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://rsp.mediar-press.net/rsp/article/view/2810</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1995-4484</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1995-4492</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">57</subfield><subfield code="j">2019</subfield><subfield code="e">6</subfield><subfield code="h">708-712</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	S. S. Rodionova
spellingShingle	S. S. Rodionova misc RC925-935 misc остеомаляция misc фактор роста фибробластов 23 misc опухоль misc гипофосфатемия misc метаболические заболевания misc Diseases of the musculoskeletal system Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
authorStr	S. S. Rodionova
ppnlink_with_tag_str_mv	@@773@@(DE-627)1736675966
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC925-935
illustrated	Not Illustrated
issn	19954492
topic_title	RC925-935 Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur остеомаляция фактор роста фибробластов 23 опухоль гипофосфатемия метаболические заболевания
topic	misc RC925-935 misc остеомаляция misc фактор роста фибробластов 23 misc опухоль misc гипофосфатемия misc метаболические заболевания misc Diseases of the musculoskeletal system
topic_unstemmed	misc RC925-935 misc остеомаляция misc фактор роста фибробластов 23 misc опухоль misc гипофосфатемия misc метаболические заболевания misc Diseases of the musculoskeletal system
topic_browse	misc RC925-935 misc остеомаляция misc фактор роста фибробластов 23 misc опухоль misc гипофосфатемия misc метаболические заболевания misc Diseases of the musculoskeletal system
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Научно-практическая ревматология
hierarchy_parent_id	1736675966
hierarchy_top_title	Научно-практическая ревматология
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1736675966
title	Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
ctrlnum	(DE-627)DOAJ083546073 (DE-599)DOAJ76e817c0e90e40e293169d3236594388
title_full	Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
author_sort	S. S. Rodionova
journal	Научно-практическая ревматология
journalStr	Научно-практическая ревматология
callnumber-first-code	R
lang_code	rus
isOA_bool	true
recordtype	marc
publishDateSort	2019
contenttype_str_mv	txt
container_start_page	708
author_browse	S. S. Rodionova A. I. Snetkov A. D. Akinshina I. V. Bulycheva A. N. Torgashin T. A. Grebennikova Zh. E. Belaya Е. M. Agafonova N. V. Toroptsova O. A. Nikitinskaya
container_volume	57
class	RC925-935
format_se	Elektronische Aufsätze
author-letter	S. S. Rodionova
doi_str_mv	10.14412/1995-4484-2019-708-712
author2-role	verfasserin
title_sort	hypophosphatemic osteomalacia induced by fgf23-secreting tumor of the left femur
callnumber	RC925-935
title_auth	Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
abstract	Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored.
abstractGer	Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored.
abstract_unstemmed	Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	6
title_short	Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
url	https://doi.org/10.14412/1995-4484-2019-708-712 https://doaj.org/article/76e817c0e90e40e293169d3236594388 https://rsp.mediar-press.net/rsp/article/view/2810 https://doaj.org/toc/1995-4484 https://doaj.org/toc/1995-4492
remote_bool	true
author2	A. I. Snetkov A. D. Akinshina I. V. Bulycheva A. N. Torgashin T. A. Grebennikova Zh. E. Belaya Е. M. Agafonova N. V. Toroptsova O. A. Nikitinskaya
author2Str	A. I. Snetkov A. D. Akinshina I. V. Bulycheva A. N. Torgashin T. A. Grebennikova Zh. E. Belaya Е. M. Agafonova N. V. Toroptsova O. A. Nikitinskaya
ppnlink	1736675966
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.14412/1995-4484-2019-708-712
callnumber-a	RC925-935
up_date	2024-07-03T18:04:02.825Z
_version_	1803582012470067201
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ083546073</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410120029.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2019 xx \|\|\|\|\|o 00\| \|\|rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14412/1995-4484-2019-708-712</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ083546073</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ76e817c0e90e40e293169d3236594388</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC925-935</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S. S. Rodionova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tumor-induced hypophosphatemic osteomalacia is a rare disease and its diagnosis presents certain difficulties. This is primarily due to small tumor size and to the absence of local clinical symptoms. Adult-onset newly diagnosed hypophosphatemia concurrent with hyperphosphaturia is a sign of tumor-induced hypophosphatemic osteomalacia. The paper describes a female patient with fibroblast growth factor 23-secreting tumor of the upper third of the femur. After tumor removal, pharmacological treatment involves prescribing calcium supplements and active vitamin D metabolite until normal bone mineral density is restored.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеомаляция</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фактор роста фибробластов 23</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">опухоль</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">гипофосфатемия</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">метаболические заболевания</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the musculoskeletal system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. I. Snetkov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. D. Akinshina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Bulycheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. N. Torgashin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. A. Grebennikova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zh. E. Belaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Е. M. Agafonova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. V. Toroptsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. A. Nikitinskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Научно-практическая ревматология</subfield><subfield code="d">IMA PRESS LLC, 2015</subfield><subfield code="g">57(2019), 6, Seite 708-712</subfield><subfield code="w">(DE-627)1736675966</subfield><subfield code="x">19954492</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:57</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:708-712</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14412/1995-4484-2019-708-712</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/76e817c0e90e40e293169d3236594388</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://rsp.mediar-press.net/rsp/article/view/2810</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1995-4484</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1995-4492</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">57</subfield><subfield code="j">2019</subfield><subfield code="e">6</subfield><subfield code="h">708-712</subfield></datafield></record></collection>
score	7.399479

Nicht das Richtige dabei?

Schreiben Sie uns!

Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?